ISRG vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Intuitive Surgical, Inc. · Healthcare
$451.29
+130.4% upside to fair value
Grade B
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$343.23
-5.3% upside to fair value
Low Conviction
Grade D
QuantHub Verdict
ISRG has more upside to fair value
(+130.4%).
ISRG trades at a lower forward P/E
(53.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
TSLA |
| Current Price |
$451.29 |
$343.23 |
| Fair Value Estimate |
$1,039.74 |
$325.00 |
| Upside to Fair Value |
+130.4%
|
-5.3%
|
| Market Cap |
$160.3B |
$1,287.9B |
| Forward P/E |
53.8x
|
205.5x
|
| EV / EBITDA |
40.5x
|
108.8x
|
| Price / Sales |
15.2x
|
13.6x
|
| Price / FCF |
64.3x
|
207.1x
|
| Revenue Growth YoY |
+23.0%
|
-2.9%
|
| Gross Margin |
66.3%
|
18.0%
|
| Operating Margin |
30.5%
|
4.6%
|
| Return on Equity |
17.0%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.55%
|
0.48%
|
| Analyst Consensus |
Strong Buy
|
—
|
Investment Thesis
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Tesla remains the most polarizing stock in markets. The core auto business is deteriorating: FY2025 revenue fell 2.9% to $94.8B, net income dropped 46.8% to $3.8B, and Q4 deliveries declined 15.6% YoY to 418K units. Yet the stock trades at 13.6x TTM P/S (near 5yr highs) on the optionality of Cybercab robotaxis launching April 2026, FSD reaching unsupervised status in Austin, and Optimus humanoid …
Accumulation Zones
| Metric |
ISRG |
TSLA |
| Zone Low |
$779.81 |
$244.00 |
| Zone High |
$883.78 |
$276.00 |
| In Buy Zone? |
Yes
|
No
|